Does TREPROSTINIL Cause Coronary artery occlusion? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Coronary artery occlusion have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
27
Reports of Coronary artery occlusion with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
1
Deaths
21
Hospitalizations
How Dangerous Is Coronary artery occlusion From TREPROSTINIL?
Of the 27 reports, 1 (3.7%) resulted in death, 21 (77.8%) required hospitalization.
Is Coronary artery occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Coronary artery occlusion?
ADALIMUMAB (1,392)
TICAGRELOR (370)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (296)
ROSUVASTATIN (283)
METOPROLOL (230)
SACUBITRIL\VALSARTAN (204)
ASPIRIN (190)
RISANKIZUMAB-RZAA (181)
EVOLOCUMAB (162)
CLOPIDOGREL BISULFATE (155)
Which TREPROSTINIL Alternatives Have Lower Coronary artery occlusion Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE